News About: Pharm. Industry
An endless patent war for dementia patches… who will be the winner between Novartis and SK?The industry has been paying attention on a result of patent litigation for dementia patches between Novartis and SK Chemicals.
The conflict has proceeded since the late 2012 b...
|
.jpg)
The beginning of the Hanmi’s first generic development for a gout medicine ‘Feburic’Hanmi Pharmaceutical started on generic development of a gout medicine ‘Feburic (Febuxostat)’ as the very first domestic pharmaceutical company in Korea.
According to Ministry ...
|
.jpg)
The current fascination of the Korean pharmaceutical market from the outside point of view
There are a great number of domestic pharmaceutical companies seeking to advance in foreign markets due to its sales limit in the Korean pharmaceutical market.
Then, the question is how multinational pharmaceutical c...
When it comes to partnerships among pharmaceutical companies… the distribution industry says “Please, stop”
While strategic partnerships among pharmaceutical companies are currently underway, pharmaceutical distribution companies are sighing with hardship.
The partnerships among pharmaceutical companies have been lasted fo...
What are the similarities among pharmaceutical companies with high revenue of products?
It is shown that pharmaceutical companies with the high number of sales of other companies’ products are more likely to be stingy about investing money on research and development (R&D).
According to the Yakupdotcom(...
Preparation of a follow-up legislation bill for the patent linkage systemInterested by the pharmaceutical industry, a follow-up legislation bill for the patent linkage system is expected to be submitted this October.
On the 7th, Minister Seung Jung,...
|
“Once new employees are hired, they do their shares of work”… Pharm companies are ‘rushing’ for public employment
Pharmaceutical companies are advancing public employment to recruit new employees of the second half of the year.
Recently, companies, such as Dong-A Group, Ahn-Gook Pharm, Green Cross, Chong Kun Dang Pharmaceutical ...
Hanmi Pharmaceutical challenges invalidity of patent for Ezetrol… A war for exclusive rights has begun
Hanmi Pharmaceutical will challenge nullity of patent for compositions of Merck’s Ezetrol(Ezetimibe), medication for hyperlipidemia.
People’s attention has been drawn to whether the challenge for the nullity would ef...
The distribution industry and GSK made a dramatic agreement for distribution cost
The conflict between the pharmaceutical distribution industry and the Korean corporate of Glaxo Smith Kline (hereinafter referring to GSK) were addressed by a dramatic agreem...
|
The most competitive companies in the pharmaceutical business will compete in the diabetic medicine market
The Korean pharmaceutical companies, such as CJ, Yuhan Corporation, Daewoong Pharm Co., will compete in the diabetic medicine market of SGLT-2 inhibitors.
As Astrazeneca(Forxiga), Boehringer Ingelheim(Jardiance), an...
